High--throughput screening of FDA--approved drugs identifies novel immunomodulatory agents for immune-mediated skin diseases

被引：0
|
作者：
Ghorbanalipoor, S. [1 ]
Matsumoto, K. [1 ]
Heimberg, L. [1 ]
Krause, M. [1 ]
Veldkamp, W. [2 ]
Magens, M. [1 ]
Zanken, J. [1 ]
Vidarsson, G. [3 ,4 ]
Visser, R. [3 ,4 ]
Kuenzel, S. [5 ]
Recke, A. [6 ,7 ]
Samavedam, U. [1 ]
Gupta, Y. [1 ]
Zillikens, D. [6 ,7 ]
Bieber, K. [1 ]
Ludwig, R. J. [1 ]
机构：
[1] Univ Lubeck, D-23562 Lubeck, Germany
[2] Radboudumc, Univ Clin, Nijmegen, Netherlands
[3] Sanquin Res, Amsterdam, Netherlands
[4] Landsteiner Lab, Amsterdam, Netherlands
[5] Max Planck Inst Evolutionary Biol, Plon, Germany
[6] Univ Lubeck, Dept Dermatol, D-23562 Lubeck, Germany
[7] Ctr Res Inflammat Skin, D-23562 Lubeck, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P094
引用
收藏
页码：E46 / E46
页数：1
相关论文
共 50 条
  • [31] High-throughput screening of approved drugs and bioactive compounds identifies aurintricarboxylic acid as a nanomolar potent antagonist of the P2X3 receptor
    Obrecht, A.
    Urban, N.
    Schaefer, M.
    Schmalzing, G.
    Hausmann, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S42 - S42
  • [32] High-throughput drug library screening identifies potent drugs and novel drug targets for high-risk acute leukemia in children
    Wander, Priscilla
    Pinhancos, Sandra S.
    Koopmans, Bianca
    Dolman, M. Emmy M.
    Schneider, Pauline
    Castro, Patricia Garrido
    Jones, Luke
    Arentsen-Peters, Susan T. C. J. M.
    Kerstjens, Mark
    Molenaar, Jan
    Caron, Huib N.
    Pieters, Rob
    Zwaan, Michel C.
    Stam, Ronald W.
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Quantitative High-Throughput Drug Screening Identifies Novel Classes of Drugs with Anticancer Activity in Thyroid Cancer Cells: Opportunities for Repurposing
    Zhang, Lisa
    He, Mei
    Zhang, Yaqin
    Nilubol, Naris
    Shen, Min
    Kebebew, Electron
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (03): : E319 - E328
  • [34] An unbiased high-throughput screening identifies repurposing drugs and novel molecules that reduce proinflammatory cytokine secretion in the context of Rheumatoid Arthritis
    Kotrulev, Martin
    Garcia-Pinel, Beatriz
    Bernardez-Alfaya, Rodrigo
    Lopez-Golan, Yolanda
    Cordero, Oscar Javier
    Sotelo, Eddy
    Varela-Calvino, Ruben
    Gomez-Tourino, Iria
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 223 - 223
  • [35] Repurposing FDA-Approved Drugs for Temozolomide-Resistant IDH1 Mutant Glioma Using High-Throughput Miniaturized Screening on Droplet Microarray Chip
    Cui, Haijun
    Sun, Xueyuan
    Schilling, Marcel
    Herold-Mende, Christel
    Reischl, Markus
    Levkin, Pavel A. A.
    Popova, Anna A. A.
    Turcan, Sevin
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (24)
  • [36] High Throughput Screening of FDA-Approved Drug Library Reveals the Compounds that Promote IRF3-Mediated Pro-Apoptotic Pathway Inhibit Virus Replication
    Glanz, Anna
    Chawla, Karan
    Fabry, Stephanie
    Subramanian, Gayatri
    Garcia, Julie
    Jay, Bryanna
    Ciricillo, Jacob
    Chakravarti, Ritu
    Taylor, R. Travis
    Chattopadhyay, Saurabh
    VIRUSES-BASEL, 2020, 12 (04):
  • [37] Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project
    Spini, Andrea
    L'Abbate, Luca
    Ingrasciotta, Ylenia
    Pellegrini, Giorgia
    Carollo, Massimo
    Ientile, Valentina
    Leoni, Olivia
    Zanforlini, Martina
    Ancona, Domenica
    Stella, Paolo
    Cavazzana, Anna
    Scapin, Angela
    Lopes, Sara
    Belleudi, Valeria
    Trifiro, Gianluca
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 395 - 407
  • [38] High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent
    Winter, Stuart S.
    Lovato, Debbie M.
    Khawaja, Hadya M.
    Edwards, Bruce S.
    Steele, Irena D.
    Young, Susan M.
    Oprea, Tudor I.
    Sklar, Larry A.
    Larson, Richard S.
    JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (03) : 185 - 193
  • [39] HIGH-THROUGHPUT PHENOTYPIC SCREENING CAMPAIGN OF 1,954 FDA-APPROVED DRUGS REVEALS 41 HITS WITH ANTI-MYOFIBROBLAST ACTIVITY IN AN IN VITRO MODEL OF PEYRONIE'S
    Ilg, M. M.
    Lapthorn, A. R.
    Muneer, A.
    Christopher, N.
    Cellek, S.
    Ralph, D. J.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S129 - S129
  • [40] Comments on "Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project" [Letter]
    Rokhmalia, Fitri
    Krihariyani, Dwi
    Luthfiyah, Sari
    Triwiyanto, T.
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 431 - 432
12345